Published in Am J Pathol on August 07, 2008
Mechanisms linking obesity and cancer. Biochim Biophys Acta (2013) 1.12
Bisphosphonates suppress insulin-like growth factor 1-induced angiogenesis via the HIF-1alpha/VEGF signaling pathways in human breast cancer cells. Int J Cancer (2010) 1.06
Insulin-like growth factor-1 regulates the SIRT1-p53 pathway in cellular senescence. Aging Cell (2014) 0.92
IGF ligand and receptor regulation of mammary development. J Mammary Gland Biol Neoplasia (2008) 0.92
Lineage tracing of mammary epithelial cells using cell-type-specific cre-expressing adenoviruses. Stem Cell Reports (2014) 0.89
The protective effect of intermittent calorie restriction on mammary tumorigenesis is not compromised by consumption of a high fat diet during refeeding. Breast Cancer Res Treat (2013) 0.79
Transgenic insulin-like growth factor-1 stimulates activation of COX-2 signaling in mammary glands. Mol Carcinog (2011) 0.79
Serum insulin-like growth factor 1 correlates with the risk of nodal metastasis in endocrine-positive breast cancer. Curr Oncol (2013) 0.79
Developmental stage determines estrogen receptor alpha expression and non-genomic mechanisms that control IGF-1 signaling and mammary proliferation in mice. J Clin Invest (2011) 0.78
The Non-coding Mammary Carcinoma Susceptibility Locus, Mcs5c, Regulates Pappa Expression via Age-Specific Chromatin Folding and Allele-Dependent DNA Methylation. PLoS Genet (2016) 0.78
A high protein moderate carbohydrate diet fed at discrete meals reduces early progression of N-methyl-N-nitrosourea-induced breast tumorigenesis in rats. Nutr Metab (Lond) (2010) 0.76
MicroRNA-206 is differentially expressed in Brca1-deficient mice and regulates epithelial and stromal cell compartments of the mouse mammary gland. Oncogenesis (2016) 0.75
Prepubertal exposure to cow's milk reduces susceptibility to carcinogen-induced mammary tumorigenesis in rats. Int J Cancer (2011) 0.75
A preliminary study of pamidronic acid downregulation of angiogenic factors IGF-1/PECAM-1 expression in circulating level in bone metastatic breast cancer patients. Onco Targets Ther (2016) 0.75
Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet (1998) 10.11
Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science (1995) 6.37
Role of the insulin-like growth factor family in cancer development and progression. J Natl Cancer Inst (2000) 5.77
The mammary pathology of genetically engineered mice: the consensus report and recommendations from the Annapolis meeting. Oncogene (2000) 4.90
Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor alpha: a new model for anti-estrogen resistance. J Biol Chem (2001) 3.86
Modelling breast cancer: one size does not fit all. Nat Rev Cancer (2007) 3.64
Sequences 5' of the bovine keratin 5 gene direct tissue- and cell-type-specific expression of a lacZ gene in the adult and during development. Differentiation (1994) 2.53
The IGF system and breast cancer. Endocr Relat Cancer (2001) 2.21
Insulin-like growth factor 1 inhibits apoptosis using the phosphatidylinositol 3'-kinase and mitogen-activated protein kinase pathways. J Biol Chem (1997) 2.12
Rates for breast cancer characteristics by estrogen and progesterone receptor status in the major racial/ethnic groups. Breast Cancer Res Treat (2002) 2.04
Enhancement of insulin-like growth factor signaling in human breast cancer: estrogen regulation of insulin receptor substrate-1 expression in vitro and in vivo. Mol Endocrinol (1999) 2.00
Mammary gland neoplasia in long-term rodent studies. Environ Health Perspect (1996) 1.94
Postnatal mammary gland morphogenesis. Microsc Res Tech (2001) 1.79
Insulin-like growth factor-I receptor overexpression mediates cellular radioresistance and local breast cancer recurrence after lumpectomy and radiation. Cancer Res (1997) 1.76
Targeted expression of des(1-3) human insulin-like growth factor I in transgenic mice influences mammary gland development and IGF-binding protein expression. Endocrinology (1996) 1.74
Function of the IGF-I receptor in breast cancer. J Mammary Gland Biol Neoplasia (2000) 1.73
Insulin-like growth factor physiology and cancer risk. Eur J Cancer (2000) 1.71
Analysis of insulin-like growth factor I gene expression in malignancy: evidence for a paracrine role in human breast cancer. Mol Endocrinol (1989) 1.65
Tumor development by transgenic expression of a constitutively active insulin-like growth factor I receptor. Cancer Res (2005) 1.58
Role of insulin-like growth factors and the type I insulin-like growth factor receptor in the estrogen-stimulated proliferation of human breast cancer cells. J Biol Chem (1990) 1.57
Deregulated activity of Akt in epithelial basal cells induces spontaneous tumors and heightened sensitivity to skin carcinogenesis. Cancer Res (2007) 1.56
Stimulation of estrogen receptor-mediated transcription and alteration in the phosphorylation state of the rat uterine estrogen receptor by estrogen, cyclic adenosine monophosphate, and insulin-like growth factor-I. Mol Endocrinol (1993) 1.56
Insulin-like growth factor (IGF)-I, IGF binding protein-3, and breast cancer risk: eight years on. Endocr Relat Cancer (2006) 1.47
Deregulated expression of insulin-like growth factor 1 in prostate epithelium leads to neoplasia in transgenic mice. Proc Natl Acad Sci U S A (2000) 1.45
IGF-I: an essential factor in terminal end bud formation and ductal morphogenesis. J Mammary Gland Biol Neoplasia (2000) 1.42
Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses Health Study II. Endocr Relat Cancer (2006) 1.40
Constitutive expression of insulin-like growth factor-1 in epidermal basal cells of transgenic mice leads to spontaneous tumor promotion. Cancer Res (2000) 1.37
Measurement of chemically induced cell proliferation in rodent liver and kidney: a comparison of 5-bromo-2'-deoxyuridine and [3H]thymidine administered by injection or osmotic pump. Carcinogenesis (1990) 1.34
Insulin-like growth factor 1 (IGF-1): a growth hormone. Mol Pathol (2001) 1.32
Insulin and insulin-like growth factor-I induce vascular endothelial growth factor mRNA expression via different signaling pathways. J Biol Chem (2000) 1.30
Circulating insulin-like growth factor-I and binding protein-3 and the risk of breast cancer. Cancer Epidemiol Biomarkers Prev (2007) 1.20
Activation of estrogen receptor-mediated gene transcription by IGF-I in human breast cancer cells. J Endocrinol (1997) 1.19
Estrogen receptor (alpha and beta) expression in the excurrent ducts of the adult male rat reproductive tract. J Androl (1998) 1.17
Insulin-like growth factors and breast cancer risk in Chinese women. Cancer Epidemiol Biomarkers Prev (2002) 1.16
The potentiation of estrogen on insulin-like growth factor I action in MCF-7 human breast cancer cells includes cell cycle components. J Biol Chem (2000) 1.14
The aetiology and pathogenesis of human breast cancer. Mutat Res (1995) 1.11
The insulin-like growth factors (IGFs) and IGF binding proteins in postnatal development of murine mammary glands. J Mammary Gland Biol Neoplasia (2000) 1.08
Insulin-like growth factor-1 inscribes a gene expression profile for angiogenic factors and cancer progression in breast epithelial cells. Neoplasia (2002) 1.04
Normal levels of serum IGF-I: determinants and validity of current reference ranges. Pituitary (2007) 1.04
Circulating IGF-I: New Perspectives for a New Century. Trends Endocrinol Metab (1999) 1.03
Hormonal and dietary modulation of mammary carcinogenesis in mouse mammary tumor virus-c-erbB-2 transgenic mice. Cancer Res (2003) 1.03
Mice expressing myrAKT1 in the mammary gland develop carcinogen-induced ER-positive mammary tumors that mimic human breast cancer. Carcinogenesis (2006) 1.03
IGF and insulin action in the mammary gland: lessons from transgenic and knockout models. J Mammary Gland Biol Neoplasia (2000) 1.03
Role of PI3K/Akt signaling in insulin-like growth factor-1 (IGF-1) skin tumor promotion. Mol Carcinog (2005) 0.98
Insulin-like growth factor I triggers nuclear accumulation of cyclin D1 in MCF-7S breast cancer cells. J Biol Chem (2002) 0.96
Role of systemic and local IGF-I in the effects of estrogen on growth and epithelial proliferation of mouse uterus. Endocrinology (2002) 0.95
Insulin-like growth factor-I induces cyclin-D1 expression in MG63 human osteosarcoma cells in vitro. Mol Endocrinol (1994) 0.95
Stabilization of cyclin D1 mRNA via the phosphatidylinositol 3-kinase pathway in MCF-7 human breast cancer cells. J Endocrinol (2000) 0.94
Insulin-like growth factors and insulin-like growth factor binding proteins in mammary gland function. Breast Cancer Res (2002) 0.91
Cooperative interaction between mutant p53 and des(1-3)IGF-I accelerates mammary tumorigenesis. Oncogene (2000) 0.91
Two promoters in expression of estrogen receptor messenger RNA in human breast cancer. Carcinogenesis (1997) 0.90
Induction of mammary cancer and lymphoma by multiple, low oral doses of 7,12-dimethylbenz[a]anthracene in SENCAR mice. Carcinogenesis (1997) 0.86
Cystic duct dilatations and proliferative epithelial lesions in mouse mammary glands upon keratin 5 promoter-driven overexpression of cyclooxygenase-2. Am J Pathol (2005) 0.85
Synergistic proliferative action of insulin-like growth factor I and 17 beta-estradiol in MCF-7S breast tumor cells. Exp Cell Res (2002) 0.85
The insulin-like growth factor-1 elevates urokinase-type plasminogen activator-1 in human breast cancer cells: a new avenue for breast cancer therapy. Mol Carcinog (2000) 0.84
Expression of ovine insulin-like growth factor-1 (IGF-1) stimulates alveolar bud development in mammary glands of transgenic mice. Endocrine (1998) 0.84
Local expression of insulin-like growth factor-I affects angiogenesis in colorectal cancer. Tumour Biol (2002) 0.82
AIN-76 diet. J Nutr (1979) 0.79
Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model. Nat Med (2004) 3.96
Disruption of Stat3 reveals a critical role in both the initiation and the promotion stages of epithelial carcinogenesis. J Clin Invest (2004) 3.70
Multi-stage chemical carcinogenesis in mouse skin: fundamentals and applications. Nat Protoc (2009) 3.14
MALAT-1: a long non-coding RNA and its important 3' end functional motif in colorectal cancer metastasis. Int J Oncol (2011) 2.59
Amplification/overexpression of a mitotic kinase gene in human bladder cancer. J Natl Cancer Inst (2002) 2.16
Cyclin D1 splice variants. Differential effects on localization, RB phosphorylation, and cellular transformation. J Biol Chem (2003) 2.12
Clearance of adenovirus by Kupffer cells is mediated by scavenger receptors, natural antibodies, and complement. J Virol (2008) 1.93
Persistent activation of the Akt pathway in head and neck squamous cell carcinoma: a potential target for UCN-01. Clin Cancer Res (2004) 1.83
Predictors of susceptibility to smoking and ever smoking: a longitudinal study in a triethnic sample of adolescents. Nicotine Tob Res (2003) 1.77
Transgenic overexpression of PKCε in the mouse prostate induces preneoplastic lesions. Cell Cycle (2011) 1.74
A multilevel adaptive finite element algorithm for bioluminescence tomography. Opt Express (2006) 1.71
Epidermal growth factor receptor-mediated activation of Stat3 during multistage skin carcinogenesis. Cancer Res (2004) 1.71
Increased frequency of circulating follicular helper T cells in patients with rheumatoid arthritis. Clin Dev Immunol (2012) 1.70
Deregulated activity of Akt in epithelial basal cells induces spontaneous tumors and heightened sensitivity to skin carcinogenesis. Cancer Res (2007) 1.56
Microstructure abnormalities in adolescents with internet addiction disorder. PLoS One (2011) 1.56
Rapid Kupffer cell death after intravenous injection of adenovirus vectors. Mol Ther (2005) 1.52
Increased frequency of follicular helper T cells in patients with autoimmune thyroid disease. J Clin Endocrinol Metab (2011) 1.50
Graphics processing unit parallel accelerated solution of the discrete ordinates for photon transport in biological tissues. Appl Opt (2011) 1.47
Source reconstruction for spectrally-resolved bioluminescence tomography with sparse a priori information. Opt Express (2009) 1.46
Experimental Cerenkov luminescence tomography of the mouse model with SPECT imaging validation. Opt Express (2010) 1.45
Coagulation factor X shields adenovirus type 5 from attack by natural antibodies and complement. Nat Med (2013) 1.45
Increased tumor growth in mice with diet-induced obesity: impact of ovarian hormones. Endocrinology (2006) 1.44
Complexity of VEGF responses in skin carcinogenesis revealed through ex vivo assays based on a VEGF-A null mouse keratinocyte cell line. J Invest Dermatol (2008) 1.42
Retrospective studies on pediatric infective endocarditis over 40 years in a mid-west area of China. Cardiology (2014) 1.42
GPU-based Monte Carlo simulation for light propagation in complex heterogeneous tissues. Opt Express (2010) 1.42
Genome-wide expression profiling of five mouse models identifies similarities and differences with human psoriasis. PLoS One (2011) 1.41
Dietary energy balance modulates signaling through the Akt/mammalian target of rapamycin pathways in multiple epithelial tissues. Cancer Prev Res (Phila) (2008) 1.41
Impact of Stat3 activation upon skin biology: a dichotomy of its role between homeostasis and diseases. J Dermatol Sci (2007) 1.40
The radiation-induced nackt (nkt) allele is a loss-of-function mutation of the mouse cathepsin L gene. J Immunol (2006) 1.40
Acupuncture modulates spontaneous activities in the anticorrelated resting brain networks. Brain Res (2009) 1.39
IKKalpha is required to maintain skin homeostasis and prevent skin cancer. Cancer Cell (2008) 1.38
A mouse optical simulation environment (MOSE) to investigate bioluminescent phenomena in the living mouse with the Monte Carlo method. Acad Radiol (2004) 1.37
Automated Delineation of Lung Tumors from CT Images Using a Single Click Ensemble Segmentation Approach. Pattern Recognit (2013) 1.36
Lack of cyclin-dependent kinase 4 inhibits c-myc tumorigenic activities in epithelial tissues. Mol Cell Biol (2004) 1.35
FMRI connectivity analysis of acupuncture effects on an amygdala-associated brain network. Mol Pain (2008) 1.32
A new algorithm for distorted fingerprints matching based on normalized fuzzy similarity measure. IEEE Trans Image Process (2006) 1.32
FMRI connectivity analysis of acupuncture effects on the whole brain network in mild cognitive impairment patients. Magn Reson Imaging (2012) 1.29
Acupuncture modulates temporal neural responses in wide brain networks: evidence from fMRI study. Mol Pain (2010) 1.28
Transcriptional regulation of estrogen receptor-alpha by p53 in human breast cancer cells. Cancer Res (2009) 1.26
Stage-specific disruption of Stat3 demonstrates a direct requirement during both the initiation and promotion stages of mouse skin tumorigenesis. Carcinogenesis (2008) 1.26
Cdk4 deficiency inhibits skin tumor development but does not affect normal keratinocyte proliferation. Am J Pathol (2002) 1.24
Progressive metaplastic and dysplastic changes in mouse pancreas induced by cyclooxygenase-2 overexpression. Neoplasia (2008) 1.24
Cyclooxygenase-2 expression is critical for chronic UV-induced murine skin carcinogenesis. Mol Carcinog (2007) 1.24
Signal transducer and activator of transcription 3 is a key regulator of keratinocyte survival and proliferation following UV irradiation. Cancer Res (2005) 1.24
Naturally occurring coumarins inhibit human cytochromes P450 and block benzo[a]pyrene and 7,12-dimethylbenz[a]anthracene DNA adduct formation in MCF-7 cells. Chem Res Toxicol (2003) 1.23
Time-varied characteristics of acupuncture effects in fMRI studies. Hum Brain Mapp (2009) 1.23
Outcome of patients with Gleason score 8 or higher prostate cancer following radical prostatectomy alone. J Urol (2002) 1.22
A streamlined three-dimensional volume estimation method accurately classifies prostate tumors by volume. Am J Surg Pathol (2003) 1.22
Two faces of the other-race effect: recognition and categorisation of Caucasian and Chinese faces. Perception (2009) 1.21
In vitro and in vivo anti-tumor activities of a gemcitabine derivative carried by nanoparticles. Int J Pharm (2011) 1.20
Interaction between genetic susceptibility and early-life environmental exposure determines tumor-suppressor-gene penetrance. Proc Natl Acad Sci U S A (2005) 1.19
Distinct roles of IL-23 and IL-17 in the development of psoriasis-like lesions in a mouse model. J Immunol (2011) 1.19
A partial intensity invariant feature descriptor for multimodal retinal image registration. IEEE Trans Biomed Eng (2010) 1.19
Correcting diastolic dysfunction by Ca2+ desensitizing troponin in a transgenic mouse model of restrictive cardiomyopathy. J Mol Cell Cardiol (2010) 1.17
Dysfunctional connectivity patterns in chronic heroin users: an fMRI study. Neurosci Lett (2009) 1.16
Serum organochlorine levels and history of lactation in Egypt. Environ Res (2003) 1.16
Interaction of systemically delivered adenovirus vectors with Kupffer cells in mouse liver. Hum Gene Ther (2008) 1.16
Fingerprint recognition with identical twin fingerprints. PLoS One (2012) 1.16
Enhanced malignant tumorigenesis in Cdk4 transgenic mice. Oncogene (2004) 1.15
A novel registration method for retinal images based on local features. Conf Proc IEEE Eng Med Biol Soc (2008) 1.14
Intrinsic brain network abnormalities in migraines without aura revealed in resting-state fMRI. PLoS One (2012) 1.14
Constitutively active Akt induces ectodermal defects and impaired bone morphogenetic protein signaling. Mol Biol Cell (2007) 1.14
Effect of systemic LPS injection on cortical NF-kappaB activity and inflammatory response following traumatic brain injury in rats. Brain Res (2004) 1.14
Carcinogenic effects of MGP-7 and B[a]P on the hamster cheek pouch. Toxicol Pathol (2009) 1.14
Spectrally resolved bioluminescence tomography with adaptive finite element analysis: methodology and simulation. Phys Med Biol (2007) 1.14
WWOX hypomorphic mice display a higher incidence of B-cell lymphomas and develop testicular atrophy. Genes Chromosomes Cancer (2007) 1.13
Expression of interleukin-8 gene in radical prostatectomy specimens is associated with advanced pathologic stage. Prostate (2005) 1.13
The enhancing effects of obesity on mammary tumor growth and Akt/mTOR pathway activation persist after weight loss and are reversed by RAD001. Mol Carcinog (2012) 1.12
Automatic renal cortex segmentation using implicit shape registration and novel multiple surfaces graph search. IEEE Trans Med Imaging (2012) 1.12
Multi-scale Convolutional Neural Networks for Lung Nodule Classification. Inf Process Med Imaging (2015) 1.12
CD133, one of the markers of cancer stem cells in Hep-2 cell line. Laryngoscope (2007) 1.11
Structural and functional abnormalities in migraine patients without aura. NMR Biomed (2012) 1.11
Urban expansion dynamics and natural habitat loss in China: a multiscale landscape perspective. Glob Chang Biol (2014) 1.11
Dietary energy balance modulates prostate cancer progression in Hi-Myc mice. Cancer Prev Res (Phila) (2011) 1.10
Glycogen synthase kinase-3 beta is involved in the phosphorylation and suppression of androgen receptor activity. J Biol Chem (2004) 1.10
Multiple signaling pathways are responsible for prostaglandin E2-induced murine keratinocyte proliferation. Mol Cancer Res (2008) 1.10
An optimal permissible source region strategy for multispectral bioluminescence tomography. Opt Express (2008) 1.10
Activation of RXR and RAR signaling promotes myogenic differentiation of myoblastic C2C12 cells. Differentiation (2009) 1.09
Stat3 as a therapeutic target for the treatment of psoriasis: a clinical feasibility study with STA-21, a Stat3 inhibitor. J Invest Dermatol (2010) 1.09
Hereditary multiple exostosis and pain. J Pediatr Orthop (2005) 1.09
Polyprodrug amphiphiles: hierarchical assemblies for shape-regulated cellular internalization, trafficking, and drug delivery. J Am Chem Soc (2013) 1.08
Inactivation of E2f1 enhances tumorigenesis in a Myc transgenic model. Cancer Res (2002) 1.08
Active Stat3 is required for survival of human squamous cell carcinoma cells in serum-free conditions. Mol Cancer (2006) 1.08
Abnormal resting brain activity in patients with functional dyspepsia is related to symptom severity. Gastroenterology (2011) 1.08
A critical role for ras-mediated, epidermal growth factor receptor-dependent angiogenesis in mouse skin carcinogenesis. Cancer Res (2002) 1.08
Tumor formation in mice with conditional inactivation of Brca1 in epithelial tissues. Oncogene (2003) 1.07
Upregulation of miR-195 increases the sensitivity of breast cancer cells to Adriamycin treatment through inhibition of Raf-1. Oncol Rep (2013) 1.07
Detecting faces in pure noise images: a functional MRI study on top-down perception. Neuroreport (2008) 1.07
Cone beam micro-CT system for small animal imaging and performance evaluation. Int J Biomed Imaging (2009) 1.07
Rapamycin is a potent inhibitor of skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate. Cancer Prev Res (Phila) (2011) 1.07
ARF differentially modulates apoptosis induced by E2F1 and Myc. Mol Cell Biol (2002) 1.07
In vivo investigation of CD133 as a putative marker of cancer stem cells in Hep-2 cell line. Head Neck (2009) 1.06
Automatic liver segmentation using a statistical shape model with optimal surface detection. IEEE Trans Biomed Eng (2010) 1.06
DNA structure-induced genomic instability in vivo. J Natl Cancer Inst (2008) 1.06